Access to anti-retroviral drugs, male in Sri Lanka

Sri Lanka: Access to anti-retroviral drugs, male was 71.0% in 2024. ◆ Volatile

Latest (2024)
71.0%
Change on year
up 16.4%
World rank
69th
of 141 countries
All-time high
71.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Sri Lanka, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 1 %2006: 2 %2007: 2 %2008: 3 %2009: 4 %2010: 6 %2011: 6 %2012: 8 %2013: 12 %2014: 15 %2015: 19 %2016: 25 %2017: 30 %2018: 35 %2019: 40 %2020: 46 %2021: 48 %2022: 54 %2023: 61 %2024: 71 %

Source: UNAIDS estimates. Measured in %.

Analysis

Sri Lanka recorded 71.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 16.4% on the previous year and up 373.3% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Sri Lanka peaked at 71.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Sri Lanka 69th out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Sri Lanka, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Sri Lanka, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 1.0%
2006 2.0% +100.0%
2007 2.0% +0.0%
2008 3.0% +50.0%
2009 4.0% +33.3%
2010 6.0% +50.0%
2011 6.0% +0.0%
2012 8.0% +33.3%
2013 12.0% +50.0%
2014 15.0% +25.0%
2015 19.0% +26.7%
2016 25.0% +31.6%
2017 30.0% +20.0%
2018 35.0% +16.7%
2019 40.0% +14.3%
2020 46.0% +15.0%
2021 48.0% +4.3%
2022 54.0% +12.5%
2023 61.0% +13.0%
2024 71.0% +16.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 1.2% 0.0% 4.0% 10
2010s 19.6% 6.0% 40.0% 10
2020s 56.0% 46.0% 71.0% 5

Countries ranked near Sri Lanka

  1. 69 Kuwait 71.0% compare
  2. 69 Nepal 71.0% compare
  3. 72 Côte d'Ivoire 69.0% compare

See the full ranking of 160 places →

More gender data for Sri Lanka

All data for Sri Lanka →

Frequently asked questions

What is access to anti-retroviral drugs, male in Sri Lanka?
Access to anti-retroviral drugs, male in Sri Lanka was 71.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Sri Lanka?
The highest recorded value was 71.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Sri Lanka?
The lowest recorded value was 0.0% in 2000.
How does Sri Lanka rank for access to anti-retroviral drugs, male?
Sri Lanka ranks 69th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Sri Lanka?
Over the last ten years it is up 373.3%. The long-run trend across the full record is volatile.
Where does this Sri Lanka data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Sri Lanka. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/sri-lanka/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/sri-lanka/">Access to anti-retroviral drugs, male in Sri Lanka</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.